Navigation Links
Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Date:8/20/2007

gemcitabine.

"As a result of the ProLindac results to date, we have put plans in place for ProLindac manufacturing scale-up in advance of starting these additional clinical trials and enrolling additional patients," added Stephen R. Seiler, Access' Chief Executive Officer. "We believe the enhanced safety profile of ProLindac will allow for more efficient and longer delivery of DACH platinum- based therapy with consequential patient benefit."

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion.

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer and MuGard(TM) for the treatment of patients with mucositis. The Company also has other advanced drug delivery technologies including vitamin-mediated targeted delivery and oral drug delivery. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties including, but not limited to statements relating to the safety profile of Prolindac, our plans to commence a further clinical trial in 4Q07 or 1Q08, the pharmacological effects of Prolindac, our ability to implement combination drug trials, that the full potential for
'/>"/>

SOURCE Access Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 The Haselmeier Group has ... Gert Weber has been nominated by the ... Chief Executive Officer (CEO) of the Haselmeier Group. ... 2015. Mr. Weber brings more than 20 years of ... filled various executive management positions, the last being Managing ...
(Date:6/30/2015)... Calif. , June 30, 2015  The MEDevice ... consecutive year, is an event dedicated to bringing medtech ... hottest issues and topics affecting the industry today. This ... address the challenges and opportunities facing today,s medtech professional ... information and to register for MEDevice San Diego, please ...
(Date:6/30/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, today announced it has submitted its fifth abbreviated ... Drug Administration (FDA) of 2015, which brings the Company,s ... FDA to twenty-seven. Jason Grenfell-Gardner , ... our current pipeline of twenty-seven submissions, exclusive of our ...
Breaking Medicine Technology:Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2
... Technologies, Incorporated (IDEV), an emerging leader in the development and ... named Christopher M. Owens its President and Chief Executive Officer, ... of results-based leadership and is the right person to take ... Anderson. "Chris has a clear vision and strategy of how ...
... Romeo and Juliette Laser Hair Removal on ... in New York City to own the newly introduced Elite ... manufacturer of laser and light-based aesthetic treatment systems. ... technology, is a highly versatile laser aesthetic workstation that combines ...
Cached Medicine Technology:IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer 2Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosure's New Elite MPX(TM) Laser System 2
(Date:7/1/2015)... ... 01, 2015 , ... B. E. Smith, the only full-service ... a national chief executive officer recruitment for Citizens Medical Center in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... ... ... Incentivizing the use of generic drugs has been an easy way for ... 90% off the prices for the brand-name products. But now that generics are experiencing ... of these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s (AIS) ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... global distribution and marketing of a number of nutritional and beauty products, announced ... the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... across platforms and devices, today announced the opening of a new operational office ... and support that enables collaboration across all lines of business for organizations throughout ...
(Date:7/1/2015)... ... 2015 , ... First Harvest Financial , a leading ... legal cannabis startups can interact with corporate executives, serial entrepreneurs and ... looking to strategically enter and capitalize on growing and creating therapeutic cannabis based ...
Breaking Medicine News(10 mins):Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3
... affecting one in 100 people worldwide. Most cases aren,t detected ... as a teenager or adult. By that time, the disease ... to treat. In a paper published recently online by ... University of North Carolina at Chapel Hill and Columbia University ...
... usually about how much of something is due to our ... research just published in the academic journal Addiction ... who smoke, drink, or use drugs, for two related reasons. ... substance use is also predisposed to choose friends who smoke, ...
... Tiger Woods ... is a procedure Dr. Manish Gupta offers at Specialty Orthopedic Center of Boca Raton, FL. ... (PRWEB) June 21, 2010 ... the focus was not on his golf game or his recent lack of. The central ...
... ... ... resident Roger Sencer was driving home from work in May 2009 when he couldn’t remember important ... him to Huntington Hospital. The news was not good: the emergency physician ran tests and ...
... and the University of Ferrara in Italy have collaborated to ... pain without causing many of the side effects of current ... of cancer patients experience pain in the final year of ... use of drugs like morphine produces side effects such as ...
... Multiple sclerosis patients who directly confronted the stress of the ... to cope with the situation by focusing on feelings. This ... researchers of the University of Haifa, the Technion-Israel Institute of ... for multiple sclerosis to date, it is important to uncover ...
Cached Medicine News:Health News:Brain signs of schizophrenia found in babies 2Health News:New research shows peer drug use may increase an individual's genetic tendency to use drugs 2Health News:Tiger Takes Another Shot: PRP Injections Put On the Spot 2Health News:3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor 2Health News:3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor 3Health News:New drugs to relieve cancer pain 2Health News:Can multiple sclerosis attacks be minimized in a war zone? 2
Tungsten Carbide wire twister....
Designed to have a shock-absorbing force, providing less bounce or wasted force....
Osteophyte periosteal elevator for bone removing....
Angled ring curette....
Medicine Products: